ARCHIVES

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

This article is from The Cancer Letter archive.

Vol. 19 No. 02 | January 8, 1993

Download PDF Visit The Full Archive

Related Articles

An Appreciation: Leonard Erickson, 1946–2013

June 7, 2013

Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;

January 10, 2003

ASCO Is a Society In Transition, Growth; Major changes over Past Year

May 24, 1996

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

June 4, 1999

Clinical Trials: NCI Issues Clinical Alert On Chemo For Cervical Cancer

February 26, 1999

NIH Strategic Plan To be Unveiled In San Antonio

January 31, 1992